Cargando…
Neuropeptide W, an endogenous NPBW1 and NPBW2 ligand, produced an analgesic effect via activation of the descending pain modulatory system during a rat formalin test
Neuropeptide W (NPW) messenger ribonucleic acid (mRNA) and NPBW1 and/or NPBW2 mRNA are expressed in the descending pain inhibitory system. In the present study, we examined whether NPW microinjected into the descending pain inhibitory system, such as the periaqueductal gray (PAG), locus coeruleus (L...
Autores principales: | Nakamura, Shingo, Nonaka, Takahiro, Yoshida, Koji, Yamada, Toshihiko, Yamamoto, Tatsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887691/ https://www.ncbi.nlm.nih.gov/pubmed/33573476 http://dx.doi.org/10.1177/1744806921992187 |
Ejemplares similares
-
Analgesic characteristics of a newly developed α(2)δ ligand, mirogabalin, on inflammatory pain
por: Komatsu, Shuji, et al.
Publicado: (2021) -
Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway
por: McPherson, Kylie B., et al.
Publicado: (2022) -
Neuropeptide W
por: Takenoya, Fumiko, et al.
Publicado: (2012) -
The Contribution of the Descending Pain Modulatory Pathway in Opioid Tolerance
por: Lueptow, Lindsay M., et al.
Publicado: (2018) -
A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA
por: Nonaka, Takahiro, et al.
Publicado: (2017)